Moravsky Beroun, Czechia

Marian Hajduch

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Olomouc, CZ (2001 - 2012)
  • Moravský Beroun, CZ (2014)
  • Moravsky Beraun, CZ (2016)
  • Moravsky Beroun, CZ (2012 - 2023)

Company Filing History:

goldMedal10 out of 31 
 
Univerzita Palackeho V Olomouci
 patents
silverMedal4 out of 27 
 
Ustav Organicke Chemie a Biochemie Av Cr, V.v.i.
 patents
bronzeMedal2 out of 2 
 
Institute of Experimental Botany of the Academy of Sciences of the Czech Republic
 patents
42 out of 5 
 
Univerzita Karlova V Praze
 patents
52 out of 4 
 
Palacky University Olomouc
 patents
62 out of 3 
 
Univerzita Karlova V Praze, Prirodovedecka Fakulta
 patents
71 out of 1 
 
Univerzita
 patent
81 out of 3 
 
Univerzita Palackeho
 patents
91 out of 1 
 
Ustav Molekularni Genetiky Akademie Ved Cr, V.v.i.
 patent
101 out of 2 
 
Helmholtz Zentrum Munchen
 patents
111 out of 13 
 
Institute of Organic Chemistry and Biochemistry Ascr, V.v.i.
 patents
121 out of 1 
 
Palacký University in Olomouc
 patent
131 out of 2 
 
Ustav Organicke Chemie a Biochemie Akademie Ved Ceske Republiky, V.v.i.
 patents
141 out of 1 
 
Ustav Molekularni Genetiky Akademie Ved Ceske Republiky, V.v.i.
 patent
151 out of 1 
 
Ustav Anorganicke Chemie Akademie Ved Ceske Republiky, V.v.i.
 patent
161 out of 1 
 
I.q.a., A.s.
 patent
171 out of 1 
 
Univerzita Palackeho V Olomouci, Lekarska Fakulta
 patent
181 out of 1 
 
Masarykuv Onkologicky Ustav
 patent
191 out of 1 
 
Univerzita Palackeho V Olomouci and I.q.a., A.s.
 patent
where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Marian Hajduch in Cancer Therapy**

Introduction

Marian Hajduch, a prominent inventor based in Moravský Beroun, Czech Republic, has made significant strides in the field of medicinal chemistry, evidenced by his 18 patents. His inventions primarily focus on novel approaches for cancer therapy, leveraging complex particle assemblies to improve treatment efficacy.

Latest Patents

Among his latest patents is the invention titled "Molecular complex assembly particles comprising bis-R1,R2-dithiocarbamate-metal complex and a ligand, method of preparation and use thereof." This innovation discloses a complex particle form of dithiocarbamate-metal compounds combined with at least one ligand, such as a polymer or detergent. The self-assembling nature of these particles, achieved through a precise process of addition of components, provides a dry form or aqueous dispersion suitable for per-oral, topical, and parenteral administration, particularly in the therapy and imaging of cancer.

Additionally, another key patent is titled "Bioavailable dithiocarbamate-metal complex particles, method of preparation and use thereof." This invention highlights a particulate form of dithiocarbamate-metal complex integrated with blood proteins, also self-assembled by a similar process. The aqueous dispersion produced holds potential for parenteral, oral, and topical applications in cancer therapy and visualization.

Career Highlights

Marian Hajduch's career has been marked by impactful work in esteemed institutions. He has contributed significantly at Palacký University Olomouc and the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. His research has been pivotal in advancing the understanding and application of complex particle systems in medicine.

Collaborations

Throughout his career, Hajduch has collaborated with several notable colleagues, including Petr Dzubak and Jan Sarek. Their joint efforts have fostered innovative research and have been essential in bringing cutting-edge solutions to the medical field, particularly in oncology.

Conclusion

Marian Hajduch's contributions to cancer therapy through his innovative patents demonstrate the potential of dithiocarbamate-metal complex particles in medical applications. His ongoing research and collaborations continue to pave the way for advancements that may significantly improve treatment outcomes for cancer patients, solidifying his role as a key figure in the field of medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…